Full history for every metric is available with a Kvantra account
Parenteral Drugs (India) Ltd. (PDPL.NS)
Key financial summary
Financials in INR| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | INR m | 2,297 | 2,168 | 320 | 240 | 122 | 85 | 85 |
| Operating profit | INR m | -0 | -29 | |||||
| Net profit | INR m | -1,152 | -1,189 | -1,479 | -1,141 | -1,217 | -764 | -764 |
| EPS reported | INR | -25.61 | -25.60 | |||||
| Operating cashflow per share | INR | -0.16 | -0.16 | |||||
| Capex per share | INR | 0.00 | 0.00 | |||||
| FCF per share | INR | -0.16 | -0.16 | |||||
| Free cash flow | INR m | -5 | 0 | |||||
| Net debt | INR m | 1,072 | 1,072 | |||||
| Book value equity | INR m | -8,240 | -8,240 | |||||
| Book value per share | INR | -276.4 | -276.4 | |||||
| Number of shares | m | 29.82 | 29.82 | |||||
| DPS (TTM paid) | INR | 0.00 | 0.00 |
Financial summary
Financials in INR| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -0.01 | -0.01 | |||||
| P/S LTM | x | 1.26 | 1.19 | |||||
| P/FCF LTM | x | -22.24 | -20.94 | |||||
| EV/EBITDA LTM | x | 3.16 | 3.15 | |||||
| EV/Sales LTM | x | 13.88 | 13.81 | |||||
| Earnings Yield LTM | % | -711.39% | -883.10% | |||||
| FCF Yield | % | -4.50% | 0.00% | |||||
| Quality | ||||||||
| ROE | % | 9.27% | 10.13% | |||||
| ROIC | % | 0.00% | 0.00% | |||||
| Operating margin | % | -0.14% | -0.14% | |||||
| Gross margin | % | 35.67% | 35.67% | |||||
| FCF/Sales | % | -5.68% | -5.68% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -30.09% | -30.09% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -0.00 | 0.00 | |||||
| Net Debt/EBITDA | x | 2.88 | 2.88 | |||||
| EBIT/Net interest | x | -0.00 | -0.00 | |||||
| Net debt/market cap | % | 998.67% | 1060.6% | |||||
| Net debt/Equity | x | -0.13 | -0.13 | |||||
| Gross debt/equity | x | -0.13 | -0.13 | |||||
Company overview
Parenteral Drugs (India) Limited operates as an India-based healthcare enterprise, specializing in the production of a diverse range of pharmaceutical goods. Its offerings encompass various medicinal products, including intravenous and inhalation therapies, as well as veterinary infusions. The company's extensive product portfolio further comprises various intravenous (IV) solutions, such as those containing carbohydrates and electrolytes, diuretics, and solutions for dialysis and irrigation. Additionally, they provide anti-infective, anti-fungal, oncology, and anesthesia medications. The firm maintains a significant international presence, exporting its goods to numerous nations including Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. Established in 1983, Parenteral Drugs (India) Limited's operations are headquartered in Indore, India.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Parenteral Drugs (India) Ltd. (PDPL.NS)
Parenteral Drugs (India) Limited operates as an India-based healthcare enterprise, specializing in the production of a diverse range of pharmaceutical goods. Its offerings encompass various medicinal products, including intravenous and inhalation therapies, as well as veterinary infusions. The company's extensive product portfolio further comprises various intravenous (IV) solutions, such as those containing carbohydrates and electrolytes, diuretics, and solutions for dialysis and irrigation. Additionally, they provide anti-infective, anti-fungal, oncology, and anesthesia medications. The firm maintains a significant international presence, exporting its goods to numerous nations including Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. Established in 1983, Parenteral Drugs (India) Limited's operations are headquartered in Indore, India.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free